Health Wire Kuwait: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Kuwait.

Press releases published on July 13, 2026

an hour ago

Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit

Indeterminate GlobeNewswire

an hour ago

Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant

Indeterminate GlobeNewswire

an hour ago

The 43rd National Pharmaceutical Industry Information Annual Conference and the 2026 Beijing · Changping Life Science Forum Held in Beijing

Indeterminate GlobeNewswire

an hour ago

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease

Indeterminate GlobeNewswire

an hour ago

Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa

Indeterminate GlobeNewswire

an hour ago

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

Indeterminate GlobeNewswire

an hour ago

EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer

Indeterminate GlobeNewswire

an hour ago

VitalHub Announces Acquisition of Buddy Healthcare

Indeterminate GlobeNewswire

an hour ago

NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness

Indeterminate GlobeNewswire

an hour ago

Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®

Indeterminate GlobeNewswire

an hour ago

Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

Indeterminate GlobeNewswire

an hour ago

Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists

Indeterminate GlobeNewswire

an hour ago

ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis

Indeterminate GlobeNewswire

3 hours ago

New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases

Indeterminate GlobeNewswire

4 hours ago

Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium

Indeterminate GlobeNewswire

4 hours ago

TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation

Indeterminate GlobeNewswire

5 hours ago

Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026

Indeterminate GlobeNewswire

6 hours ago

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Indeterminate GlobeNewswire

6 hours ago

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Indeterminate GlobeNewswire

7 hours ago

SCENESSE® approved for EPP in Canada

Indeterminate GlobeNewswire